<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29592806</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>09</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1423-0127</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Mar</Month>
              <Day>28</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomedical science</Title>
          <ISOAbbreviation>J Biomed Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway.</ArticleTitle>
        <Pagination>
          <StartPage>27</StartPage>
          <MedlinePgn>27</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">27</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-018-0431-7</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">β-aminoisobutyric acid (BAIBA) is produced in skeletal muscle during exercise and has beneficial effects on obesity-related metabolic disorders such as diabetes and non-alcoholic fatty liver disease. Thus, it is supposed to prevent high fat diet (HFD)-induced inflammation and insulin resistance in adipose tissue though anti-inflammatory effects in obesity. Previous reports have also demonstrated strong anti-inflammatory effects of BAIBA.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used BAIBA treated fully differentiated 3T3T-L1 mouse adipocytes to investigate the effects of exogenous BAIBA on inflammation and insulin signaling in adipocytes. Insulin signaling-mediated proteins and inflammation markers were measured by Western blot analysis. Secretion of pro-inflammatory cytokines were measured by ELISA. Lipid accumulation in differentiated 3 T3-L1 cells was stained by Oil red-O. Statistical analysis was performed by ANOVA and student's t test.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">BAIBA treatment suppressed adipogenesis assessed by adipogenic markers as well as lipid accumulation after full differentiation. We showed that BAIBA treatment stimulated AMP-activated protein kinase (AMPK) phosphorylation in a dose-dependent manner and lipopolysaccharide (LPS)-induced secretion of pro-inflammatory cytokines such as TNFα and MCP-1 was abrogated in BAIBA-treated 3 T3-L1 cells. Treatment of 3 T3-L1 cells with BAIBA reduced LPS-induced NFκB and IκB phosphorylation. Furthermore, BAIBA treatment ameliorated LPS-induced impairment of insulin signaling measured by IRS-1 and Akt phosphorylation and fatty acid oxidation. Suppression of AMPK by small interfering (si) RNA significantly restored these changes.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We demonstrated anti-inflammatory and anti-insulin resistance effects of BAIBA in differentiated 3 T3-L1 cells treated with LPS through AMPK-dependent signaling. These results provide evidence for the beneficial effects of BAIBA not only in liver and skeletal muscle cells but also in adipose tissue.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jung</LastName>
            <ForeName>Tae Woo</ForeName>
            <Initials>TW</Initials>
            <AffiliationInfo>
              <Affiliation>Research Administration Team, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Hyung Sub</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>Geum Hee</ForeName>
            <Initials>GH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Daehwan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Taeseung</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0001-6425-5924</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam, 463-707, Korea. tslee@snubh.org.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. tslee@snubh.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Biomed Sci</MedlineTA>
        <NlmUniqueID>9421567</NlmUniqueID>
        <ISSNLinking>1021-7770</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000621">Aminoisobutyric Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>T68ALE2O9F</RegistryNumber>
          <NameOfSubstance UI="C033435">3-aminoisobutyric acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D041721" MajorTopicYN="N">3T3-L1 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000621" MajorTopicYN="N">Aminoisobutyric Acids</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AMPK</Keyword>
        <Keyword MajorTopicYN="N">Adipocyte</Keyword>
        <Keyword MajorTopicYN="N">BAIBA</Keyword>
        <Keyword MajorTopicYN="N">Inflammation</Keyword>
        <Keyword MajorTopicYN="N">Insulin resistance</Keyword>
        <Keyword MajorTopicYN="N">NFκB</Keyword>
      </KeywordList>
      <CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: All procedures performed in this work were in accordance with the ethical standards of the institutional and/or national research committee. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: All authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29592806</ArticleId>
        <ArticleId IdType="pmc">PMC5875012</ArticleId>
        <ArticleId IdType="doi">10.1186/s12929-018-0431-7</ArticleId>
        <ArticleId IdType="pii">10.1186/s12929-018-0431-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bluher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009;117(6):241–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19358089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–2971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18775919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC296998</ArticleId>
            <ArticleId IdType="pubmed">14679177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okabe TA, Kishimoto C, Murayama T, Yokode M, Kita T. Effects of exercise on the development of atherosclerosis in apolipoprotein E-deficient mice. Exp Clin Cardiol. 2006;11(4):276–279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2274844</ArticleId>
            <ArticleId IdType="pubmed">18651017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Letteron P, Fromenty B. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency. Obesity. 2008;16(9):2053–2067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19186330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts LD, Bostrom P, O'Sullivan JF, Schinzel RT, Lewis GD, Dejam A, Lee YK, Palma MJ, Calhoun S, Georgiadi A, Chen MH, Ramachandran VS, Larson MG, Bouchard C, Rankinen T, Souza AL, Clish CB, Wang TJ, Estall JL, Soukas AA, Cowan CA, Spiegelman BM, Gerszten RE. Beta-Aminoisobutyric acid induces browning of white fat and hepatic beta-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014;19(1):96–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4017355</ArticleId>
            <ArticleId IdType="pubmed">24411942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011;25(18):1895–1908.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3185962</ArticleId>
            <ArticleId IdType="pubmed">21937710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med. 2011;89(7):667–676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3111671</ArticleId>
            <ArticleId IdType="pubmed">21431325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kjobsted R, Treebak JT, Fentz J, Lantier L, Viollet B, Birk JB, Schjerling P, Bjornholm M, Zierath JR, Wojtaszewski JF. Prior AICAR stimulation increases insulin sensitivity in mouse skeletal muscle in an AMPK-dependent manner. Diabetes. 2015;64(6):2042–2055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25552597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes. 2002;51(10):2886–2894.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12351423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liong S, Lappas M. Activation of AMPK improves inflammation and insulin resistance in adipose tissue and skeletal muscle from pregnant women. J Physiol Biochem. 2015;71(4):703–717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26407807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung TW, Hwang HJ, Hong HC, Yoo HJ, Baik SH, Choi KM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARdelta-dependent pathway in mice. Diabetologia. 2015;58(9):2096–2105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26105792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi CX, Zhao MX, Shu XD, Xiong XQ, Wang JJ, Gao XY, Chen Q, Li YH, Kang YM, Zhu GQ. Beta-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes. Sci Rep. 2016;6:21924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4764829</ArticleId>
            <ArticleId IdType="pubmed">26907958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Qian J, Zhao X, Xing C, Sun B. Beta-Aminoisobutyric acid ameliorates the renal fibrosis in mouse obstructed kidneys via inhibition of renal fibroblast activation and fibrosis. J Pharmacol Sci. 2017;133(4):203–213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28433566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanda Y, Matsuda M, Tawaramoto K, Kawasaki F, Hashiramoto M, Matsuki M, Kaku K. Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: implication of different mechanism from pioglitazone. Diabetes Res Clin Pract. 2008;81(1):13–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18455831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caton PW, Kieswich J, Yaqoob MM, Holness MJ, Sugden MC. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes Obes Metab. 2011;13(12):1097–1104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21733059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009;9(5):407–416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19416711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z, Wang X, He Y, Qi L, Yu L, Xue B, Shi H. The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1. PLoS One. 2012;7(11):e49935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3503857</ArticleId>
            <ArticleId IdType="pubmed">23183898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Wang P, Zhuang Y, Lin H, Li Y, Liu L, Meng Q, Cui T, Liu J, Li Z. Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Lett. 2011;585(12):1735–1740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21536037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prieto-Hontoria PL, Fernandez-Galilea M, Perez-Matute P, Martinez JA, Moreno-Aliaga MJ. Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes. J Physiol Biochem. 2013;69(3):595–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23307774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7(1):45–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18177724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escote X, Gomez-Serrano M, Peral B, Salvado L, Fernandez-Veledo S, Casals N, Vazquez-Carrera M, Villarroya F, Vendrell JJ, Serra D, Herrero L. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am J Physiol Endocrinol Metab. 2015;308(9):E756–E769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25714670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osler ME, Zierath JR. Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology. 2008;149(3):935–941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18202133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11(11):738–749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3383854</ArticleId>
            <ArticleId IdType="pubmed">21984069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37(5):365–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4044307</ArticleId>
            <ArticleId IdType="pubmed">24781408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7678183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW., Jr Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–1808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC296995</ArticleId>
            <ArticleId IdType="pubmed">14679176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8971073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinor AD, Lillien L. Akt-1 expression level regulates CNS precursors. J Neurosci. 2004;24(39):8531–8541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6729906</ArticleId>
            <ArticleId IdType="pubmed">15456827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 2002;277(50):48115–48121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12351658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo S. Molecular basis of insulin resistance: the role of IRS and Foxo1 in the control of diabetes mellitus and its complications. Drug Discov Today Dis Mech. 2013;10(1–2):e27–e33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3763863</ArticleId>
            <ArticleId IdType="pubmed">24015152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Scie STKE. 2005;2005(268):pe4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15671481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inukai K, Watanabe M, Nakashima Y, Takata N, Isoyama A, Sawa T, Kurihara S, Awata T, Katayama S. Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2005;328(2):484–490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15694373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W, Tang S, Shi J, Yin W, Cao S, Bu R, Zhu D, Bi Y. Metformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase/sterol regulatory element-binding protein-1c pathway. Int J Mol Med. 2015;35(6):1734–1740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25891779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sola D, Rossi L, Schianca GP, Maffioli P, Bigliocca M, Mella R, Corliano F, Fra GP, Bartoli E, Derosa G. Sulfonylureas and their use in clinical practice. Arch Med Sci. 2015;11(4):840–848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4548036</ArticleId>
            <ArticleId IdType="pubmed">26322096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miralles-Linares F, Puerta-Fernandez S, Bernal-Lopez MR, Tinahones FJ, Andrade RJ, Gomez-Huelgas R. Metformin-induced hepatotoxicity. Diabetes Care. 2012;35(3):e21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3322705</ArticleId>
            <ArticleId IdType="pubmed">22355024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes. 2008;57(12):3239–3246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2584129</ArticleId>
            <ArticleId IdType="pubmed">18829989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2246086</ArticleId>
            <ArticleId IdType="pubmed">18053812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196–4200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9398739</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
